Worth noting, CVS Caremark—the biggest PBM in the U.S.— announced in May that it would make Novo Nordisk’s rival drug Wegovy ...

Leaving the Obamacare exchange, closing some Oak Street clinics and taking a $5.7 billion charge have CVS Health on a better financial path.

Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication more accessible nationwide.

November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or ...

Explore how GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are impacting obesity rates in America, while also highlighting ...

A sleep apnea device company that’s been a darling of Minnesota’s medtech scene lost more than 40% of its value in the past five days as investors realized the competitive threat posed by new weight ...